Dissolvable magnesium stent could revolutionize heart disease treatment
NCT ID NCT07258290
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study tests a new device called Freesolve, a temporary magnesium scaffold that props open blocked heart arteries and then dissolves over time. About 1,859 people with up to two new blockages will receive either this scaffold or a standard permanent stent. The goal is to see if the magnesium scaffold is as safe and effective at keeping arteries open and preventing heart attacks or repeat procedures after one year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charleston Area Medical Center
RECRUITINGCharleston, West Virginia, 25304, United States
-
MedStar Washington Hospital Center
RECRUITINGWashington D.C., District of Columbia, 20010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Software-Guided heart procedures: a new standard for coronary care?
- Virtual reality may distract patients from pain and fear during anesthesia
- Can better healthcare access save hearts after prison?
- Heart patients may stay active longer with coach calls and group support